Double-Blind Study of Tocilizumab Plus Methotrexate Vs Tocilizumab Plus Placebo in Patients with Active Rheumatoid Arthritis Despite Prior Methotrexate : Progression of Structural Damage, Quality of Life, and Physical Function At 24 Weeks.